Cargando…

T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Fisicaro, Paola, Boni, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773863/ https://www.ncbi.nlm.nih.gov/pubmed/35053296 http://dx.doi.org/10.3390/cells11020180

Ejemplares similares

Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer
por: Zecca, Alessandra, et al.
Publicado: (2022)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
por: Liu, Pingyi, et al.
Publicado: (2018)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy
por: Chiang, Jason, et al.
Publicado: (2023)

NK Cell-Based Immunotherapy in Renal Cell Carcinoma
por: Terrén, Iñigo, et al.
Publicado: (2020)

Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Ailioaie, Laura Marinela, et al.
Publicado: (2020)

The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
por: Warricker, Frazer, et al.
Publicado: (2021)

Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C
por: Barili, Valeria, et al.
Publicado: (2021)

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Way to go to exploit NK cells' versatile talents for cancer immunotherapy
por: Cho, Duck
Publicado: (2014)

Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005)

Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers
por: Barili, Valeria, et al.
Publicado: (2023)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Prospects for NK-based immunotherapy of chronic HBV infection
por: Jin, Xiaomeng, et al.
Publicado: (2022)

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
por: Jang, Byoung Kuk
Publicado: (2016)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
por: Yu, Yanlin
Publicado: (2023)

NK Cell-Based Glioblastoma Immunotherapy
por: Golán, Irene, et al.
Publicado: (2018)

NK Cell-Based Immunotherapies in Cancer
por: Shin, Min Hwa, et al.
Publicado: (2020)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2023)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
por: Kim, Sung Eun
Publicado: (2017)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice
por: Celsa, Ciro, et al.
Publicado: (2023)

NK Cell-Based Immunotherapy in Colorectal Cancer
por: Della Chiesa, Mariella, et al.
Publicado: (2022)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

NK Cell-Based Immunotherapy in Cancer Metastasis
por: Lorenzo-Herrero, Seila, et al.
Publicado: (2018)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
por: Lee, Chang Hun, et al.
Publicado: (2021)

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
por: Chun, Ho Soo, et al.
Publicado: (2021)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
por: Perisetti, Abhilash, et al.
Publicado: (2021)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Datfar, Toofan, et al.
Publicado: (2021)

Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk
por: Jarcuska, Peter, et al.
Publicado: (2018)

Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib
por: Simão, Adélia
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r038hcfus9j86lilhb1cthv8rb